HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nobuyuki Yoshio Selected Research

Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)

3/2020High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura.
4/2018High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nobuyuki Yoshio Research Topics

Disease

2Hemorrhage
03/2020 - 04/2018
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2020 - 04/2018
2Leukemia
06/2005 - 02/2002
1Febrile Neutropenia
10/2022
1Invasive Fungal Infections
10/2022
1Liver Diseases (Liver Disease)
10/2022
1Mycoses (Diseases, Fungus)
10/2022
1Neutropenia
10/2022
1Hematologic Neoplasms (Hematological Malignancy)
10/2022
1Lymphoid Leukemia
02/2002
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2002

Drug/Important Bio-Agent (IBA)

2Dexamethasone (Maxidex)FDA LinkGeneric
03/2020 - 04/2018
2Inosine Triphosphate (ITP)IBA
03/2020 - 04/2018
1ElectrolytesIBA
10/2022
1Prednisolone (Predate)FDA LinkGeneric
03/2020
1fludarabineIBA
06/2005
1UracilIBA
02/2002
1Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2002
1TegafurIBA
02/2002

Therapy/Procedure

4Therapeutics
10/2022 - 02/2002
2Drug Therapy (Chemotherapy)
10/2022 - 02/2002
1Hematopoietic Stem Cell Transplantation
10/2022
1Remission Induction
02/2002